W. Lin, Z. Lin, and M. Zhang, “The Therapy of Osimertinib for EGFR Mutation—Non-small Cell Lung Cancer”, HSET, vol. 6, pp. 219–229, Jul. 2022, doi: 10.54097/hset.v6i.964.